- Home
- MMLP vs PLRX Comparison
MMLP vs PLRX Comparison
Compare MMLP & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- PLRX
- Stock Information
- Founded
- MMLP 2002
- PLRX 2015
- Country
- MMLP United States
- PLRX United States
- Employees
- MMLP N/A
- PLRX N/A
- Industry
- MMLP Oil Refining/Marketing
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MMLP Energy
- PLRX Health Care
- Exchange
- MMLP Nasdaq
- PLRX Nasdaq
- Market Cap
- MMLP 139.6M
- PLRX 165.5M
- IPO Year
- MMLP 2002
- PLRX 2020
- Fundamental
- Price
- MMLP $3.58
- PLRX $3.08
- Analyst Decision
- MMLP
- PLRX Buy
- Analyst Count
- MMLP 0
- PLRX 10
- Target Price
- MMLP N/A
- PLRX $14.86
- AVG Volume (30 Days)
- MMLP 84.3K
- PLRX 3.4M
- Earning Date
- MMLP 02-12-2025
- PLRX 03-07-2025
- Dividend Yield
- MMLP 0.56%
- PLRX N/A
- EPS Growth
- MMLP N/A
- PLRX N/A
- EPS
- MMLP N/A
- PLRX N/A
- Revenue
- MMLP $707,622,000.00
- PLRX N/A
- Revenue This Year
- MMLP $4.19
- PLRX N/A
- Revenue Next Year
- MMLP N/A
- PLRX N/A
- P/E Ratio
- MMLP N/A
- PLRX N/A
- Revenue Growth
- MMLP N/A
- PLRX N/A
- 52 Week Low
- MMLP $2.28
- PLRX $2.43
- 52 Week High
- MMLP $4.13
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- MMLP 48.48
- PLRX 22.51
- Support Level
- MMLP $3.44
- PLRX $2.92
- Resistance Level
- MMLP $3.67
- PLRX $3.16
- Average True Range (ATR)
- MMLP 0.17
- PLRX 0.85
- MACD
- MMLP 0.00
- PLRX -0.39
- Stochastic Oscillator
- MMLP 45.16
- PLRX 6.22
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.